Physician profile
Loan Tran
NPI 1548818446
$1,605.00
in general payments reported to CMS, 2019-2025
19 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $294 · 2022: $283 · 2023: $455 · 2024: $239 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $306.86 | 2021-2025 | |
| Lilly USA, LLC | $294.57 | 2021-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $186.39 | 2022-2024 | Jardiance |
| Abbvie INC. | $178.17 | 2022-2025 | |
| Exact Sciences Corporation | $129.30 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ardelyx, INC. | $77.43 | 2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.76 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $60.58 | 2023-2024 | Gardasil 9, Capvaxive, Gardasil |
| Novo Nordisk INC | $54.00 | 2021-2025 | |
| Vbi Vaccine (Delaware) INC. | $40.77 | 2022 | |
| Jazz Pharmaceuticals INC. | $37.20 | 2021 | |
| Inspire Medical Systems, INC. | $31.54 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $29.91 | 2025 | |
| Vanda Pharmaceuticals INC. | $26.12 | 2025 | Fanapt |
| Horizon Therapeutics Plc | $19.31 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.16 | 2022 | |
| Radius Health, INC. | $17.61 | 2024 | Tymlos |
| Alexion Pharmaceuticals, INC. | $16.86 | 2022 | |
| Eisai INC. | $15.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.